Edition:
United Kingdom

VBI Vaccines Inc (VBIV.OQ)

VBIV.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
5:29pm GMT
Change (% chg)

$0.06 (+1.59%)
Prev Close
$3.77
Open
$3.56
Day's High
$3.88
Day's Low
$3.56
Volume
39,960
Avg. Vol
66,853
52-wk High
$6.59
52-wk Low
$3.05

Chart for

About

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity.... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $156.09
Shares Outstanding(Mil.): 40.23
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-VBI Vaccines Announces Changes To Its Board Of Directors

* VBI VACCINES INC - TOMER KARIV, CHAIRMAN AND CEO OF PONTIFAX GROUP, TO REPLACE RAN NUSSBAUM ON VBI'S BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

26 Jan 2018

BRIEF-VBI Vaccines adds Ran Nussbaum to board

* Vbi vaccines strengthens board of directors with appointment of ran nussbaum Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

02 Nov 2017

BRIEF-VBI Vaccines announces full exercise of option to purchase additional shares, upsized registered direct offering for proceeds of $71.9 mln

* VBI Vaccines announces full exercise of underwriters’ option to purchase additional shares and upsized registered direct offering for aggregate proceeds of $71.9 million

30 Oct 2017

BRIEF-VBI vaccines prices concurrent public offering and registered direct offering

* VBI Vaccines prices concurrent public offering and registered direct offering for aggregate proceeds of $63.5 million

26 Oct 2017

BRIEF-VBI Vaccines announces proposed concurrent public offering

* VBI Vaccines announces proposed concurrent public offering and registered direct offering of common shares

25 Oct 2017

REFILE-BRIEF-VBI Vaccines Inc entered into amendment to amended and restated credit agreement and guaranty​

* VBI Vaccines Inc - ‍ on Sept 28 borrower, co, guarantors and perceptive entered into an amendment to amended and restated credit agreement and guaranty​

02 Oct 2017

BRIEF-Levon extends a gold enriched sulphide zone through the Cordero Ag, Zn, Pb, Au Resource

* Levon extends a gold enriched sulphide zone through the Cordero Ag, Zn, Pb, Au Resource with 2017 infill drilling, aimed at improving starter pit economic projections Source text for Eikon: Further company coverage:

26 Sep 2017

Earnings vs. Estimates